Proteome Sciences (LON:PRM) Issues Quarterly Earnings Results

Proteome Sciences (LON:PRM) released its quarterly earnings data on Wednesday. The company reported GBX (0.41) earnings per share for the quarter, Digital Look Earnings reports. Proteome Sciences had a negative net margin of 81.50% and a positive return on equity of 33.80%.

Proteome Sciences Price Performance

PRM stock traded down GBX 0.24 during trading on Thursday, hitting GBX 1.21. The stock had a trading volume of 5,279,079 shares, compared to its average volume of 402,580. Proteome Sciences has a twelve month low of GBX 1.11 and a twelve month high of GBX 4.40. The company’s 50-day moving average price is GBX 1.71 and its two-hundred day moving average price is GBX 1.64. The company has a debt-to-equity ratio of -165.46, a current ratio of 0.13 and a quick ratio of 0.37. The stock has a market capitalization of £4.24 million, a P/E ratio of -1.16 and a beta of 0.16.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.